Phase ii/iii study of intraperitoneal chemotherapy after neoadjuvant chemotherapy for ovarian cancer: ncic ctg ov.21. - Wikidata - awgldk - TriplyDB

Phase ii/iii study of intraperitoneal chemotherapy after neoadjuvant chemotherapy for ovarian cancer: ncic ctg ov.21.

Phase ii/iii study of intraperitoneal chemotherapy after neoadjuvant chemotherapy for ovarian cancer: ncic ctg ov.21.

http://www.wikidata.org/entity/Q34628651

about

Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.The basics of CAR T design and challenges in immunotherapy of solid tumors - Ovarian cancer as a model.Simulation of Chemoperfusion Treatment for Abdominal Carcinomatosis.Evaluation of biosafety and intracellular uptake of Cremophor EL free paclitaxel elastic liposomal formulation.Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.Both heat and new chemotherapeutic drug dioxadet in hyperthermic intraperitoneal chemoperfusion improved survival in rat ovarian cancer model.

P2860

Q24186509-9CE0AE72-2255-4CEA-BC04-6A64037ECD31 Q24201686-F9870FEE-0BC1-48A8-B643-13C891E0C173 Q24235235-4F55F9BE-6173-470A-AD0D-218C3B282EB7 Q33626973-8785FE3A-6712-410B-9021-D6F59FD49119 Q38748836-0508C547-AD34-4C3B-84B0-60D3B10EB797 Q38868563-06763635-7AC9-4DF2-A316-D0B4AEFB945A Q39445090-B356BC15-6B17-4E22-9CC6-F8C29EFBF49F Q53054061-E91D9F77-C3C4-424F-BAFC-3501D8FAC288 Q53233948-B155E2E7-98E6-4B75-9F73-1ED77922988F

P2860

Phase ii/iii study of intraperitoneal chemotherapy after neoadjuvant chemotherapy for ovarian cancer: ncic ctg ov.21.

http://www.wikidata.org/entity/Q34628651

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Phase ii/iii study of intraper ...... varian cancer: ncic ctg ov.21.

@ast

Phase ii/iii study of intraper ...... varian cancer: ncic ctg ov.21.

@en

Phase ii/iii study of intraper ...... varian cancer: ncic ctg ov.21.

@nl

type

label

Phase ii/iii study of intraper ...... varian cancer: ncic ctg ov.21.

@ast

Phase ii/iii study of intraper ...... varian cancer: ncic ctg ov.21.

@en

Phase ii/iii study of intraper ...... varian cancer: ncic ctg ov.21.

@nl

prefLabel

Phase ii/iii study of intraper ...... varian cancer: ncic ctg ov.21.

@ast

Phase ii/iii study of intraper ...... varian cancer: ncic ctg ov.21.

@en

Phase ii/iii study of intraper ...... varian cancer: ncic ctg ov.21.

@nl

P1433

Q34628651-DD4EB3D2-F45C-472F-9FDA-EC8E8AE6A6A2

P1476

Q34628651-2F05FD63-DF51-4C60-8986-F8ADCC9693C6

P2093

Q34628651-13549055-4A03-4373-B133-324649F9F145

Q34628651-272BB485-E9ED-44B3-B400-80270C137C29

Q34628651-2969BF6A-24DD-4D56-BDA7-9F0A1DC2FF29

Q34628651-2FFB6F72-0E7F-4D01-8D2C-F5A0A988CDCF

Q34628651-6021D852-2080-4303-88FE-C9112F25216F

Q34628651-9578A838-B85F-45E1-B15F-BB3A90C5ECB9

Q34628651-C9CF4F6C-D197-4F18-93FF-B0F3907A62BD

P2860

Q34628651-119C20A9-83D7-4566-93C4-3434C2E0A771

Q34628651-216D90F8-31BC-45D2-85A5-BF0A6D730E50

Q34628651-3DE449F8-6562-4F6E-A7A9-A41673BE8780

Q34628651-418DADF2-70A8-463F-BB71-F9212BAD3CB1

Q34628651-69AE5B85-7570-40AD-B6E1-6BD7ACE7A84B

Q34628651-6F376425-CC1C-4450-89AE-7C40D1CD5FD9

Q34628651-6FCFEE33-D21F-4E83-AE31-A83DECC4A82B

Q34628651-7944F322-4AD3-4FEE-8D30-E80F05322A0D

Q34628651-84C2E43F-E77B-42A7-BDC3-D52B6229E278

Q34628651-84EDB0E5-7756-4AFF-A46E-3FF87DD36B33

P304

Q34628651-F716002F-0154-42BF-9B3F-BFFC5FE709E3

P31

Q34628651-7DF5E39A-0017-4F35-89B6-2ED0C80C82B9

P356

Q34628651-DD5D8391-EBBE-4566-AF36-CF0EAEBDCA49

P433

Q34628651-77F37119-AFA5-4394-81C7-FADD16B2B789

P478

Q34628651-5DA4B4E1-35CA-4053-A5F0-1C67AFF4BC2A

P577

Q34628651-1BB08B7E-E83D-43FC-A672-58F6C7FE4516

P5875

Q34628651-15116CDE-92C0-4911-9858-51013156DAC6

P698

Q34628651-A91A533B-28DD-4A5F-A196-9E8C905C7EC8

P921

Q34628651-56AC313F-A045-40DF-B094-B555A6E5880E

Q34628651-B1B9BEA0-2FFD-41BF-ACD2-CB9B54BC66F5

P932

Q34628651-537E06DA-FF09-44C3-A305-EB9A109412E5

P356

P1433

Current Oncology

P1476

Phase ii/iii study of intraper ...... varian cancer: ncic ctg ov.21.

@en

P2093

A M Oza

http://www.w3.org/2001/XMLSchema#string

D Provencheur

http://www.w3.org/2001/XMLSchema#string

D Tu

http://www.w3.org/2001/XMLSchema#string

E A Eisenhauer

http://www.w3.org/2001/XMLSchema#string

H J Mackay

http://www.w3.org/2001/XMLSchema#string

M Heywood

http://www.w3.org/2001/XMLSchema#string

R Meyer

http://www.w3.org/2001/XMLSchema#string

P2860

Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer

Cancer statistics, 2008

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

A comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for stage III ovarian cancer.

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G

A phase II trial of weekly paclitaxel and every 3 weeks of carboplatin in potentially platinum-sensitive ovarian and peritoneal carcinoma.

Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group.

Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.

Cancer of the ovary.

Morphological effects of chemotherapy on ovarian carcinoma

P304

84-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3747/CO.V18I2.725

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51063211

http://www.w3.org/2001/XMLSchema#string

P698

21505599

http://www.w3.org/2001/XMLSchema#string

P921

P932

3070707

http://www.w3.org/2001/XMLSchema#string